Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

OxThera created to advance Q-Med's oxalate project

July 14, 2005

Phase IIb study evaluates BXL-628 for benign prostatic hyperplasia

July 13, 2005

Novartis and P&G to copromote Enablex in U.S.

July 11, 2005

Anti-PDGF-D antibody ameliorates mesangioproliferative glomerulonephritis

July 7, 2005

Lipoxygenase inhibitor decreases proteinuria, preserves renal function in diabetic nephropathy

July 6, 2005

Therapeutic agents for fibrotic disorders reported by Nihon University

June 30, 2005

DA-8159 prevents erectile dysfunction associated with hypercholesterolemia

June 28, 2005

Tamsulosin OCAS begins roll-out in Europe

June 23, 2005

Sosei cleared to begin U.K. phase II study for SOU-001

June 22, 2005

Clinical trials confirm the benefits of conivaptan in patients with hyponatremia

June 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...